COVID-19
Researchers have identified a protective genetic factor against severe COVID-19. A study published in JCI Insight found that the high-affinity CD16A polymorphism, present in approximately 66% of the population, reduces the risk of ICU admission, mechanical ventilation, and severe disease trajectories in patients hospitalized with COVID-19. This genetic variation enhances
COVID-19
A new report from Semnan University in Iran presents fresh data on nanoparticles, highlighting the importance of efficient respiratory face masks in the context of the COVID-19 pandemic. The research focuses on fabricating an antiviral respiratory face mask electrospun technology and optimizing its parameters through response surface methodology (RSM). The
COVID-19
Researchers from the Graduate University of Advanced Technology in Iran have made a significant discovery in the fight against COVID-19. By analyzing the inhibitory effects of major phenolic compounds from ginger, including gingerol, paradol, and shogaol, against the main protease (Mpro) of SARS-CoV-2, they found that shogaol exhibited the strongest
COVID-19
Investigators at the National Institute of Environmental Health Sciences have published new research on the use of hyaluronan therapy in treating viral pneumonia. According to the study, hyaluronan, a glycosaminoglycan found in the epithelial glycocalyx, has beneficial effects in lung injury and can be used as a broadly effective prophylactic
COVID-19
A team of researchers from the U.S. Food and Drug Administration has developed a new approach to identify potential treatments for COVID-19. The study, which was published in the journal Molecules, used a combination of machine learning, molecular dynamics, and molecular docking to identify potential inhibitors of the papain-like
COVID-19
Research conducted at the Instituto Conmemorativo Gorgas de Estudios de la Salud has shed light on the potential use of antimalarial compounds in treating COVID-19. The study evaluated the antiviral activity of 26 compounds against the Delta and A2.5 variants of SARS-CoV-2, isolated in Panama between 2020 and 2022.
COVID-19
New research published in the Journal of Infection and Chemotherapy has found that booster vaccination significantly reduces the risk of oxygen deterioration in COVID-19 patients, particularly those with comorbidities. The study, conducted by researchers at the Nagoya University Graduate School of Medicine in Japan, analyzed data from 596 hospitalized mild-to-moderate
COVID-19
Research conducted by the National Academy of Sciences of Ukraine has yielded promising results in the development of new inhibitors against the SARS-CoV-2 virus. The study employed a multitask machine learning approach to evaluate the antiviral effectiveness of different chemical compounds against the main protease (M) of the virus. The
COVID-19
Researchers at Sungkyunkwan University have engineered an antiviral platform using filamentous bacteriophages conjugated with multivalent 9-O-acetylated sialic acid ligands (Ac-SLPhage) to target conserved viral entry pathways of human coronavirus OC43 (HCoV-OC43), a surrogate for SARS-CoV-2. This nanomaterial competitively blocks viral attachment through high-affinity interactions with host sialic acid receptors, while
COVID-19
Researchers from Islamic Azad University in Iran have made a significant discovery in the fight against COVID-19, finding that allicin-nanocomplexes exhibit strong binding affinity and favorable electronic properties, making them a promising candidate for treating the disease. The study, published in Scientific Reports, used advanced computational techniques to investigate the
COVID-19
A team of scientists from the VIB-UGent Center for Medical Biotechnology has made a groundbreaking discovery, identifying a unique class of small antibodies that can strongly protect against a wide range of SARS coronaviruses, including SARS-CoV-1 and various SARS-CoV-2 variants. These antibodies target a highly conserved site at the base
COVID-19
Researchers at Cardiff University have made a significant breakthrough in understanding the SARS-CoV-2 virus, which causes COVID-19. The study focused on the spike glycoprotein, a crucial component of the virus that facilitates entry into host cells. By exploring the fatty acid binding pocket within the S protein, the researchers identified
